DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

AUGMENTIN 1gm In Skin And Soft Tissue Infection

Information source: GlaxoSmithKline
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Skin Diseases, Infectious; Infection, Soft Tissue

Intervention: amoxicillin/clavulanate potassium 1gm (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: GlaxoSmithKline

Official(s) and/or principal investigator(s):
GSK Clinical Trials, Study Director, Affiliation: GlaxoSmithKline


Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections

Clinical Details

Official title: An Open, Non-comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan

Study design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Clinical response at 10 - 14 days post therapy

Secondary outcome: Clinical response at on-therapy evaluation visit (2 - 4 days following initiation of therapy and 48 - 96 hours post therapy) Bacteriological response at (2 - 4 days following initiation of therapy, 48 - 96 hours post therapy, 10 - 14 days post therapy)


Minimum age: 12 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- having diagnosed uncomplicated soft tissue infection (e. g furuncle, cellulitis)

- has given freely documented consent.

Exclusion Criteria:

- antibiotics

- have renal or hepatic insufficiency

- systemic toxicity

- pregnancy

- lactation

- hypersensitivity to penicillin or Beta-lactam antibiotics

Locations and Contacts

GSK Investigational Site, Karachi, Pakistan

GSK Investigational Site, Lahore 54000, Pakistan

GSK Investigational Site, Lahore, Pakistan

Additional Information

Starting date: December 2004
Last updated: November 21, 2012

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017